Derivatives of apoptolidin, including skeletal homologues, are potent and selective apoptosis-inducing agents which, unlike apoptolidin, do not undergo isomerization under physiological conditions. These compounds exhibit antitumor properties, often superior to those of apoptolidin, and as such can be used in the treatment of cancer and other hyperproliferative disorders.
Apoptolidin的衍
生物,包括骨架同系物,是强效且选择性的诱导凋亡剂,与apoptolidin不同的是,在生理条件下不会发生异构化。这些化合物表现出抗肿瘤特性,通常优于apoptolidin,因此可以用于治疗癌症和其他过度增殖性疾病。